You may also like
ECMO Support in Fulminant Myocarditis (EP Video)
Dafne Chianella discusses strategies for ECMO support in a patient with Fulminant Myocarditis (22:30 minutes).
1 min read
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
It is our hope that the present document will encourage and stimulate future prospective studies and randomized trials to study the safety, efficacy, and optimal use of these agents for prevention or management of thrombosis in COVID-19.
1 min read
The Risk Associated with Aprotinin in Cardiac Surgery
In this observational study involving 4374 patients undergoing revascularization, we prospectively assessed three agents (aprotinin [1295 patients], aminocaproic acid [883], and tranexamic acid [822]) as compared with no agent (1374 patients) with regard to serious outcomes by propensity and multivariable methods.
1 min read
